pharmaphorum

DECEMBER 30, 2021

Johnson & Johnson’s much-touted crop of bispecific antibodies for cancer generated its first commercial product in May, and the drugmaker has now filed for FDA approval of a second candidate. The latest to reach the regulatory stage is teclistamab, one of two bispecifics for multiple myeloma in the late-stage pipeline of J&J’s Janssen division stemming from its longstanding and fertile collaboration with Danish biotech Genmab.

Chemotherapy 120

Chemotherapy Immunity Immunization 120

NY Times

DECEMBER 30, 2021

Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.

Vaccines 98

Vaccines Hospitals Immunity Immunization 98

Drug Patent Watch

DECEMBER 30, 2021

[![bortezomib structure]([link] Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three…. The post New tentative approval for Hospira Inc drug bortezomib appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Packaging Solutions

DECEMBER 30, 2021

Central’s Chrismon Tree began in 1977, when the women of the church made the first ornaments for our church tree. The number of Christian Christmas symbols on our tree has grown each year until we now have over one hundred. Our Chrismons are made in white, the liturgical color of Christmas, which refers to Christ’s purity and perfection, and gold, which refers to his majesty and glory.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

DECEMBER 29, 2021

Sanofi and Regeneron have another challenger to their big-selling drug Dupixent for atopic dermatitis, now that the FDA has approved Leo Pharma’s rival antibody tralokinumab. IL-13 inhibitor tralokinumab has been cleared by the US regulator as Adbry as a treatment for moderate-to-severe atopic dermatitis in adults who can’t control symptoms using topical prescription therapies.

Labelling 105

Labelling 105

NY Times

DECEMBER 30, 2021

The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.

79

79

Pharma Packaging Solutions

DECEMBER 30, 2021

2022! A fresh year, we hope. A new start, we pray. A chance to leave past pain and struggle in the past. But what are we moving toward? What are our dreams and aspirations, especially as a community of faith? Dare we ask what are God’s dreams for us as a community of faith? Our theme for 2022 is “Jesus 365.” We begin the year with a journey through Luke’s gospel, picking up the story this Sunday when Jesus is 12 years old and left behind in Jerusalem.

52

52

pharmaphorum

DECEMBER 31, 2021

The jury in a new York trial has found that Teva Pharmaceuticals played a role in fuelling the opioid crisis in the US, and should be held liable for damages, which will be decided later. The decision came after eight days of deliberation by the jurors, and almost six months of legal jousting between the drugmaker and its counsel and lawyers for the state of New York and two of its counties, Suffolk and Nassau.

Packaging 52

Packaging Immunity Immunization 52

NY Times

DECEMBER 30, 2021

Regulators will also allow even younger children with immune deficiencies to get an extra shot.

Immunity 98

Immunity Immunization Vaccines 98

Drug Patent Watch

DECEMBER 29, 2021

Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…. The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Physician Pharmacist

DECEMBER 29, 2021

You may be wondering, “why is this guy talking to me about choosing a specialty right. now? All I want to do is know how to get into medical school.” I completely understand where you are coming from, however it's also imperative to recognize that every medical specialty isn't ideal for a transitioning pharmacist. I also realize that you will have plenty of time throughout medical school to soul-search and find your true passion.

Medical Schools 52

Medical Schools 52

Pharma Packaging Solutions

DECEMBER 28, 2021

We’ve likely all experienced beautiful sunrises in various places. Perhaps a never-ending ocean? An expansive high desert where one can see forever? A peaceful Smoky Mountain lookout? The broad Texas or Oklahoma plains? Your own backyard with multicolored sky? We’re reminded that day is not ending, but gloriously beginning. “O Holy Night” gives us imagery of the first Advent with the line, “for yonder breaks a new and glorious morn.

52

52

NY Times

DECEMBER 31, 2021

Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.

72

72

Drug Patent Watch

DECEMBER 27, 2021

Annual Drug Patent Expirations for ACCUNEB Accuneb is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There is one…. The post New patent expiration for Mylan Speciality drug ACCUNEB appeared first on DrugPatentWatch - Make Better Decisions.

52

52

The Physician Pharmacist

DECEMBER 28, 2021

Learn how to apply strategically to maximize application results, while minimizing your financial burden! Although every applicant’s experience will be different the financial burden of applying to medical school is often a shared experience. Regardless of your upbringing it is important to recognize that applying is NOT a cost-free endeavor. As a pharmacy student/recent graduate, you will likely already have a substantial amount of debt.

Medical Schools 52

Medical Schools 52

Pharma Packaging Solutions

DECEMBER 27, 2021

But those who hope in the Lord will renew their strength. They will soar on wings like eagles; they will run and not grow weary, they will walk and not be faint. Isaiah 40:30 NIV This is my God story – a story of His peace, His love, and my hope. My hope was in the Lord during a long difficult journey of recovery and rehabilitation after a near-fatal car accident.

52

52

NY Times

DECEMBER 28, 2021

Un tratamiento que puede ayudar a la gente que necesita anteojos para ver de cerca, sin afectar su visión de largo alcance, salió al mercado en diciembre tras ser aprobado por la FDA en octubre.

54

54

Drug Patent Watch

DECEMBER 27, 2021

Annual Drug Patent Expirations for DUONEB Duoneb is a drug marketed by Mylan Speciality Lp and is included in one NDA. There is one patent protecting this drug. This drug…. The post New patent expiration for Mylan Speciality drug DUONEB appeared first on DrugPatentWatch - Make Better Decisions.

52

52

The Physician Pharmacist

DECEMBER 27, 2021

As a pharmacy student applying to medical school, we are often unaware of how competitive the application cycle really is. We've done well enough in school to get accepted into an accredited pharmacy program, but what does "well enough" even mean in the context of medicine? Most pharmacy students/graduates decide against making the switch and have never considered a different profession.

Medical Schools 52

Medical Schools 52

PharmaKinnex

DECEMBER 27, 2021

CASE STUDY First-Time Generic Product Launch Situation Product launch of a first-time generic product in the glaucoma market. Challenges. Different formulation than currently available reference branded product. Not available in every EMR platform initially. Need to re-create the market for this previously discontinued formulation. Approach. High potential targets were selected based upon their historical prescribing pattern of the branded reference drug.

52

52

Pharma Packaging Solutions

DECEMBER 26, 2021

“Holy, holy, holy, is the Lord God Almighty, Who was and is and is to come!” Revelation 4:8b ESV Sometimes in our lives there seems to be the repetition of a thing, event, wise counsel, or even a concept. As strange as it may seem, the concept of holy has been in my life as long as I can remember. As a small child, I was brought to church where we sang the hymn, “Holy, Holy, Holy” I liked that hymn, to say the word though I did not have any understanding of its meaning.

52

52

Board Vitals - Pharmacist

DECEMBER 26, 2021

Are you getting ready to take your Family Nurse Practitioner Exam? Getting started in studying can be daunting. You need to prioritize time to study and prepare — and take practice questions! The best thing to do to get started is to narrow down what exam you’re going to be planning for. We’ve broken down the ANCC and AANP exams for you so you can find the right fit. 5 Tips for Successful Studying 1.

52

52

Pharmacy Joe

DECEMBER 29, 2021

In this episode, I’ll discuss why I think a recent study about 3 days of outpatient remdesivir is probably not going to catch on. Episode 674: Why 3 days of outpatient remdesivir is probably not going to catch on Subscribe on iTunes , Android , or Stitcher In the past week, a randomized trial was published in NEJM titled Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.

Vaccines 40

Vaccines Inpatient Hospitals 40

PharmaKinnex

DECEMBER 27, 2021

CASE STUDY Product Launch of New Dosage Strength Situation Product launch for new dosage strength of an existing product within the SNRI generic market. Challenges. Incomplete coverage of commercial insurances. Not available in every EMR platform initially. Changing physician prescribing habits to include new dosage strength in their treatment regiments.

Dosage 52

Dosage 52

Pharma Packaging Solutions

DECEMBER 25, 2021

But because of his great love for us, God, who is rich in mercy, made us alive with Christ even when we were dead in transgressions—it is by grace you have been saved. Ephesians 2:4-5 NIV The vivid lyrics of “O Holy Night” transport us to the night of a miracle beyond our comprehension – the birth of the long-awaited Messiah. We see the bright stars and hear angelic voices announcing news of “great joy” and hope.

52

52

Drug Patent Watch

DECEMBER 29, 2021

[![bortezomib structure]([link] Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three…. The post New tentative approval for Hospira Inc drug bortezomib appeared first on DrugPatentWatch - Make Better Decisions.

40

40

Med Ed 101

DECEMBER 29, 2021

In this gout case study, a 66-year-old female has a past medical history of diabetes, neuropathy, depression, migraines, insomnia, gout, and hypertension. She has numerous complaints. Her gout has not been in good control as she is requiring significant indomethacin use for flare management. She says that capsaicin doesn’t help her knee pain. In addition, […].

Diabetes 40

Diabetes 40

PharmaKinnex

DECEMBER 27, 2021

CASE STUDY First-Time Generic Product Launch Situation Product launch of a first-time generic product in the glaucoma market. Challenges. Different formulation than currently available reference branded product. Not available in every EMR platform initially. Need to re-create the market for this previously discontinued formulation. Approach. High potential targets were selected based upon their historical prescribing pattern of the branded reference drug.

52

52

Pharmacy Joe

DECEMBER 26, 2021

In this episode, I’ll discuss a novel metric for antibiotic stewardship. Episode 673: Is this a better metric for antibiotic stewardship? Subscribe on iTunes , Android , or Stitcher Days of Therapy (DOT) is probably the most common metric to track antimicrobial stewardship efforts related to antibiotic consumption. DOT is not a perfect metric as it is calculated by calendar day regardless of the number of doses given, however, it is easily calculated which probably contributes to its popul

Inpatient 40

Inpatient Hospitals 40

Drug Patent Watch

DECEMBER 28, 2021

[![bortezomib structure]([link] Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three…. The post New tentative approval for Hospira Inc drug bortezomib appeared first on DrugPatentWatch - Make Better Decisions.

40

40

Med Ed 101

DECEMBER 26, 2021

In the video below I discuss 2022 BCPS Exam information, content outline, and study materials. Critical points from the video include: What to study when it comes to each of the major sections of the 2022 BCPS exam content outline Pharmacotherapy (65% of the exam) Application of Evidence in Practice and Education (25% of the […]. The post 2022 BCPS Exam Information, Content Outline, and Study Materials appeared first on Med Ed 101.

40

40

PharmaKinnex

DECEMBER 27, 2021

CAREERS Career Listing One Job Title. Job Location. Requirements (degree, skills). Morbi ut purus venenatis, feugiat purus nec, condimentum tortor. Proin ac lorem in lacus tristique molestie. Vivamus eu enim faucibus, vulputate leo eget, aliquet leo. Curabitur porta augue eu nibh iaculis faucibus. Pellentesque eleifend, tellus ut egestas imperdiet, lacus ante rhoncus lacus, ut cursus enim arcu eu elit.

40

40

NY Times

DECEMBER 27, 2021

It is the first pill approved in the nation to treat symptoms of the coronavirus.

53

53

Drug Patent Watch

DECEMBER 27, 2021

[![bortezomib structure]([link] Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three…. The post New tentative approval for Hospira Inc drug bortezomib appeared first on DrugPatentWatch - Make Better Decisions.

40

40

Drug Patent Watch

DECEMBER 27, 2021

DUONEB (albuterol sulfate; ipratropium bromide) Mylan speciality lp Patent: 6,632,842 Expiration: Dec 28, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…. The post Drug Patent Expirations for the Week of December 26, 2021 appeared first on DrugPatentWatch - Make Better Decisions.

40

40